DK0951287T3 - Oral sammensætning omfattende 5-aminosalicylsyre - Google Patents

Oral sammensætning omfattende 5-aminosalicylsyre

Info

Publication number
DK0951287T3
DK0951287T3 DK97918973T DK97918973T DK0951287T3 DK 0951287 T3 DK0951287 T3 DK 0951287T3 DK 97918973 T DK97918973 T DK 97918973T DK 97918973 T DK97918973 T DK 97918973T DK 0951287 T3 DK0951287 T3 DK 0951287T3
Authority
DK
Denmark
Prior art keywords
oral
ulcers
salicylic acid
oral composition
disease
Prior art date
Application number
DK97918973T
Other languages
English (en)
Inventor
Thomas Buser
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Application granted granted Critical
Publication of DK0951287T3 publication Critical patent/DK0951287T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK97918973T 1996-08-13 1997-08-12 Oral sammensætning omfattende 5-aminosalicylsyre DK0951287T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9617001.4A GB9617001D0 (en) 1996-08-13 1996-08-13 Oral composition
PCT/EP1997/004376 WO1998006387A2 (en) 1996-08-13 1997-08-12 Oral composition comprising 5-aminosalicylic acid

Publications (1)

Publication Number Publication Date
DK0951287T3 true DK0951287T3 (da) 2002-12-09

Family

ID=10798432

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918973T DK0951287T3 (da) 1996-08-13 1997-08-12 Oral sammensætning omfattende 5-aminosalicylsyre

Country Status (12)

Country Link
US (1) US6217897B1 (da)
EP (1) EP0951287B1 (da)
JP (1) JP4597273B2 (da)
AT (1) ATE227131T1 (da)
AU (1) AU4298597A (da)
CA (1) CA2263070C (da)
DE (1) DE69716947T2 (da)
DK (1) DK0951287T3 (da)
ES (1) ES2188933T3 (da)
GB (1) GB9617001D0 (da)
PT (1) PT951287E (da)
WO (1) WO1998006387A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
MXPA03006699A (es) * 2001-01-26 2004-05-31 Univ Emory Metodos de induccion de tolerancia al trasplante de organos y correccion de hemoglobinopatias.
CA2473143A1 (en) * 2002-02-08 2003-08-14 Johnson & Johnson Gmbh Compositions containing oat straw and willowherb extract
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
IE20070129A1 (en) * 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EA020856B1 (ru) 2009-02-16 2015-02-27 Джулиани Интернэшнл Лимитед Способы лечения патологических состояний, связанных с волосами
US20140030354A1 (en) * 2011-03-09 2014-01-30 Paul F. Reid Composition and method for oral delivery of cobra venom
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
EP2844242A1 (en) 2012-04-18 2015-03-11 Nogra Pharma Limited Methods of treating lactose intolerance
CN102697937A (zh) * 2012-06-28 2012-10-03 王佳丽 一种治疗口腔溃疡的药物及其制备方法
RU2540493C1 (ru) * 2013-12-10 2015-02-10 Гюзель Маратовна Акмалова Способ местного лечения красного плоского лишая слизистой оболочки полости рта типичной формы
EP3921299B1 (en) 2019-02-08 2024-11-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
CN113350277A (zh) * 2021-06-30 2021-09-07 广东科伦药业有限公司 一种治疗化疗口腔黏膜炎的美沙拉秦含漱液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065980T3 (es) 1988-05-05 1995-03-01 Tillotts Pharma Ag Uso del acido 5-aminosalicilico en el tratamiento de alteraciones dermatologicas.
DK254289D0 (da) * 1989-05-25 1989-05-25 Dumex Ltd As Middel til behandling af svampeinfektioner
US5262164A (en) 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
NL9000237A (nl) * 1990-01-31 1991-08-16 Re Novative Drugs For Dermatol Topicale farmaceutische composities voor de mondholte en vagina.
AU685262B2 (en) 1994-03-30 1998-01-15 Gs Development Ab Use of fatty acid esters as bioadhesive substances

Also Published As

Publication number Publication date
DE69716947D1 (de) 2002-12-12
EP0951287B1 (en) 2002-11-06
GB9617001D0 (en) 1996-09-25
PT951287E (pt) 2003-03-31
JP2000516227A (ja) 2000-12-05
US6217897B1 (en) 2001-04-17
WO1998006387A3 (en) 1998-03-19
ES2188933T3 (es) 2003-07-01
ATE227131T1 (de) 2002-11-15
CA2263070C (en) 2009-09-08
CA2263070A1 (en) 1998-02-19
AU4298597A (en) 1998-03-06
JP4597273B2 (ja) 2010-12-15
WO1998006387A2 (en) 1998-02-19
DE69716947T2 (de) 2003-07-17
EP0951287A2 (en) 1999-10-27

Similar Documents

Publication Publication Date Title
PT951287E (pt) Composicao oral compreendendo acido 5-aminossalicilico
NZ236797A (en) Topical compositions comprising ibuprofen (or s-ibuprofen) dissolved in a hydroalcoholic gel having a ph of 3.5 to 6.0 and use thereof
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
IL154693A (en) Use of testosterone gel to make a remedy for testosterone deficiency in women
WO1996028148A3 (en) Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
Garb Nevus Verrucosus Unilateris Cured with Podophyllin Ointment: Ointment Applied as Occlusive Dressings; Report of a Case
EP0282316A3 (en) Wound dressings in sheet or gelled paste form
JPS57171912A (en) Cream
CA2140545A1 (en) Use of first runnings coconut fatty acid as insect-repellent
FI896321A7 (fi) Aktiiviainetta sisältävät mikrorakeet, jotka koostuvat pääasiassa kyllästettyjen rasvahappojen triglyseridistä, ja niiden käyttö paikallisesti sairaanhoitoalalla
IT1275556B (it) Procedimento ed impianto per la disidratazione di foraggio, particolarmente per la disidratazione dell'erba medica
SE9403158D0 (sv) New use of prostaglandins
EP0094714A3 (en) Gel-like calcium salt of 1-hydroxy-3-aminopropane-1,1-diphosphonic acid
NZ336600A (en) Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation
ID24062A (id) Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
BR8803821A (pt) Metodo e composicao para a liberacao ativada a umidade e transporte no solo de um agente biologicamente ativo
RU99117143A (ru) Применение дихлорбензилового спирта для получения лекарственного средства для местного лечения воспаления и лекарственное средство, содержащее дихлорбензиловый спирт
DE69513109D1 (de) Holunder enthaltendes Hautpflegemittel
RU96124022A (ru) Способ лечения красного плоского лишая слизистой оболочки полости рта
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
SE9001963D0 (sv) Foerfarande foer framstaellning av en polyakrylatgel
ATE97812T1 (de) Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.
IE34883L (en) Treatment of marek's disease with ureidodiphenyl sulfone
ATE294568T1 (de) Zusammensetzung zur behandlung von verbrennungen
UA885A1 (uk) Засiб для лiкуваhhя шлуhково-кишкових захворюваhь з озhаками дiареї